Literature DB >> 8176103

Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: correlations with dobutamine-atropine stress test.

J Baptista1, M Arnese, J R Roelandt, P Fioretti, D Keane, J Escaned, E Boersma, C di Mario, P W Serruys.   

Abstract

OBJECTIVES: The purpose of this study was to determine the predictive value of quantitative coronary angiography in the assessment of the functional significance of coronary stenosis as judged from the development of left ventricular wall motion abnormalities during dobutamine-atropine stress echocardiography.
BACKGROUND: Coronary angiography is the reference method for assessment of the accuracy of noninvasive diagnostic imaging techniques to detect the presence of significant coronary stenosis. However, use of arbitrary cutoff criteria for the interpretation of angiographic data may considerably influence the true diagnostic accuracy of the technique investigated.
METHODS: Thirty-four patients without previous myocardial infarction and with single-vessel coronary stenosis were studied with both quantitative angiography and dobutamine-atropine stress echocardiography. Two different techniques of quantitative angiographic analysis--edge detection and videodensitometry--were used for measurement of minimal lumen diameter, percent diameter stenosis and percent area stenosis. Two-dimensional echocardiographic images were collected during incremental doses of intravenous dobutamine and later analyzed using a 16-segment left ventricular model. Angiographic cutoff criteria were derived from receiver-operating curves to define the functional significance of coronary stenosis on the basis of dobutamine-atropine stress echocardiography.
RESULTS: The angiographic cutoff values with the best predictive value for the development of left ventricular wall motion abnormalities during dobutamine-atropine stress echocardiography were minimal lumen diameter of 1.07 mm, percent diameter stenosis of 52% and percent area stenosis of 75%. Minimal lumen diameter was found to have the best predictive value for a positive dobutamine stress test (odds ratio 51, sensitivity 94%, specificity 75%).
CONCLUSIONS: Automated quantitative angiographic measurement of minimal lumen diameter is a practical and useful index for determining both the anatomic and functional significance of coronary stenosis, and a value of 1.07 mm is the best predictor for a positive dobutamine stress test.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176103     DOI: 10.1016/0735-1097(94)90388-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease.

Authors:  A Elhendy; R T van Domburg; F B Sozzi; D Poldermans; J J Bax; J R Roelandt
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women.

Authors:  Abdou Elhendy; Arend F L Schinkel; Jeroen J Bax; Ron T van Domburg; Roelf Valkema; Elena Biagini; Harm H Feringa; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

3.  Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era.

Authors:  Young Bin Song; Sang-Yeub Lee; Joo-Yong Hahn; Seung-Hyuk Choi; Jin-Ho Choi; Sang Hoon Lee; Kyung Pyo Hong; Jeong Euy Park; Hyeon-Cheol Gwon
Journal:  Heart Vessels       Date:  2011-07-16       Impact factor: 2.037

4.  Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.

Authors:  Sanjaya K Satapathy; Jason M Vanatta; Ryan A Helmick; Albert Flowers; Satish K Kedia; Yu Jiang; Bilal Ali; James Eason; Satheesh P Nair; Uzoma N Ibebuogu
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

5.  A novel catecholamine, arbutamine, for a pharmacological cardiac stress agent.

Authors:  R Nagarajan; G Abou-Mohamed; T Myers; R W Caldwell
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

6.  Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography.

Authors:  F B Sozzi; D Poldermans; J J Bax; A Elhendy; E C Vourvouri; R Valkema; J De Sutter; A F Schinkel; A Borghetti; J R Roelandt
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 7.  Adequate patient selection for coronary revascularization: an overview of current methods used in daily clinical practice.

Authors:  Steven A J Chamuleau; Berthe L F van Eck-Smit; Martijn Meuwissen; Jan J Piek
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

8.  The elusive link between coronary lesion morphology and dobutamine stress echocardiography results. The EDIC (Echo Dobutamine International Cooperative) Study Group.

Authors:  J Heyman; P Salvadé; E Picano; A Varga; E Gliozheni; R Sicari; M Previtali; G Rovelli
Journal:  Int J Card Imaging       Date:  1997-10

9.  Acute Beta Blockade at Peak Stress: Will It Alter the Sensitivity of Dobutamine Stress Echocardiography in Patients with Normal Resting Wall Motion?

Authors:  Zainab Abdel-Salam; Mohamed Ghazy; Mohamed Khaled; Wail Nammas
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

10.  Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischaemia assessed by quantitative MIBI SPET imaging.

Authors:  A Elhendy; M L Geleijnse; J R Roelandt; J H Cornel; R T van Domburg; A E Reijs; P R Nierop; P M Fioretti
Journal:  Eur J Nucl Med       Date:  1996-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.